Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing

Shoji, Mikio, Golde, Todd E., Ghiso, Jorge, Cheung, Tobun T., Estus, Steven, Shaffer, Lillian M., Cai, Xiao-Dan, McKay, Deborah M. +3 more·1992·Science
DOI 10.1126/science.1439760

Cited by (1,002)

Items 201–300 of 1,002

  1. Uptake, Degradation, and Release of Fibrillar and Soluble Forms of Alzheimer's Amyloid β-Peptide by Microglial Cells
    Chung, Haeyong, Brazil, Melanie I., Soe, Thwe Thwe, Maxfield, Frederick R. · 1999 · Journal of Biological Chemistry
  2. The Toxicity of the Alzheimer's β-Amyloid Peptide Correlates with a Distinct Fiber Morphology
    Bernd Seilheimer, Bernd Bohrmann, Luca Bondolfi, Francis Müller, Dietrich Stüber, Heinz Döbeli · 1997 · Journal of Structural Biology
  3. Systemic Catabolism of Alzheimer's Aβ40 and Aβ42
    Ghiso, Jorge, Shayo, Marcos, Calero, Miguel, Ng, Douglas, Tomidokoro, Yasushi, Gandy, Samuel, Rostagno, Agueda, Frangione, Blas · 2004 · Journal of Biological Chemistry
  4. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
    Craig William Ritchie, Nadja Smailagic, Anna H Noel-Storr, Obioha Chukwunyere Ukoumunne, Emma C Ladds, Steven Martin · 2017 · Cochrane Database of Systematic Reviews
  5. Molecular genetics of Alzheimer's disease: An update
    Nathalie Brouwers, Kristel Sleegers, Christine Van Broeckhoven · 2008 · Annals of Medicine
  6. Trafficking of cell surface beta-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons.
    Tsuneo Yamazaki, Dennis J. Selkoe, Edward H. Koo · 1995 · The Journal of Cell Biology
  7. High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy.
    Nobuhiro Suzuki, Takeshi Iwatsubo, Asano Odaka, Y Ishibashi, Chieko Kitada, Yasuo Ihara · 1994 · PubMed Central
  8. Intramembrane Proteolysis by γ-Secretase
    Harald Steiner, Regina Fluhrer, Christian Haass · 2008 · Journal of Biological Chemistry
  9. Neutral endopeptidase can hydrolyze β-amyloid(1–40) but shows no effect on β-amyloid precursor protein metabolism
    Steve W. Howell, Josephine N. Nalbantoglu, Philippe Crine · 1995 · Peptides
  10. Presenilin, Notch, and the genesis and treatment of Alzheimer's disease
    Dennis J. Selkoe · 2001 · Proceedings of the National Academy of Sciences
  11. NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation.
    M Yoshimoto, Akihiko Iwai, David E. Kang, D A Otero, Yu Xia, Tsunao Saitoh · 1995 · Proceedings of the National Academy of Sciences
  12. Metal ions, Alzheimer's disease and chelation therapy
    Budimir, Ana · 2011 · Acta Pharmaceutica
  13. Amyloid β Protein Starting Pyroglutamate at Position 3 Is a Major Component of the Amyloid Deposits in the Alzheimer's Disease Brain
    Harigaya, Yasuo, Saido, Takaomi C., Eckman, Christopher B., Prada, Cristian-Mihail, Shoji, Mikio, Younkin, Steven G. · 2000 · Biochemical and Biophysical Research Communications
  14. Alzheimer Disease
    Mark A. Smith · 1998 · International review of neurobiology
  15. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease
    Chuang Guo, Tao Wang, Wei Hui Zheng, Zhongyan Shan, Weiping Teng, Zhan‐You Wang · 2012 · Neurobiology of Aging
  16. Metallothioneins in Brain—The Role in Physiology and Pathology
    Michael Aschner, M. George Cherian, Curtis D. Klaassen, Richard D. Palmiter, Jay C. Erickson, Ashley Ian Bush · 1997 · Toxicology and Applied Pharmacology
  17. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling
    Steffen Roßner · 1998 · Progress in Neurobiology
  18. Characterization of Apolipoprotein J-Alzheimer's Aβ Interaction
    Etsuro Matsubara, Blas Frangione, Jorge A. Ghiso · 1995 · Journal of Biological Chemistry
  19. Insulin signaling, glucose metabolism and mitochondria: Major players in Alzheimer's disease and diabetes interrelation
    Sónia C. Correia, Renato X. Santos, Cristina Carvalho, Susana Cardoso, Emanuel Candeias, Maria S. Santos, Catarina Resende Oliveira, Paula Isabel Moreira · 2012 · Brain Research
  20. Amyloid β Protein-(1–42) Forms Calcium-permeable, Zn2+-sensitive Channel
    Seung Keun Rhee, Arjan Pieter Quist, Ratneshwar Lal · 1998 · Journal of Biological Chemistry
  21. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Aβ oligomerization
    Fernanda G. De Felice, Marcelo N. N. Vieira, Leonardo Martins Saraiva, José Daniel Figueroa‐Villar, José Garcia-Abreu, Roy Liu, Lei Chang, W L Klein, Sergio Teixeira Ferreira · 2004 · The FASEB Journal
  22. Aβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers
    Nelson J. Arispe, Juan Carlos Díaz, Olga Šimáková · 2007 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  23. β-Amyloid peptides as direct cholinergic neuromodulators: a missing link?
    Daniel S. Auld, Satyabrata Kar, Rémi Quirion · 1998 · Trends in Neurosciences
  24. Muscarinic Regulation of Alzheimer's Disease Amyloid Precursor Protein Secretion and Amyloid β-Protein Production in Human Neuronal NT2N Cells
    Bryan A. Wolf, Andrew M. Wertkin, Y. Camille Jolly, Robert P. Yasuda, Barry B. Wolfe, Robert J. Konrad, David R. Manning, Sanjiv Ravi, JOHN R. WILLIAMSON, Virginia M.‐Y. Lee · 1995 · Journal of Biological Chemistry
  25. Amyloidosis and Alzheimer’s disease
    Jorge A. Ghiso, Blas Frangione · 2002 · Advanced Drug Delivery Reviews
  26. β-Secretase Processing in the Trans-Golgi Network Preferentially Generates Truncated Amyloid Species That Accumulate in Alzheimer’s Disease Brain
    Jason T. Huse, Kangning Liu, Donald S. Pijak, Dan Carlin, Virginia M.‐Y. Lee, Robert W. Doms · 2002 · Journal of Biological Chemistry
  27. Cleavage of Alzheimer's Amyloid Precursor Protein (APP) by Secretases Occurs after O-Glycosylation of APP in the Protein Secretory Pathway
    Susumu Tomita, Yutaka Kirino, Toshiharu Suzuki · 1998 · Journal of Biological Chemistry
  28. Degradation of Alzheimer's ß-Amyloid Protein by Human and Rat Brain Peptidases: Involvement of Insulin-Degrading Enzyme
    JOHN R. MCDERMOTT, ALISON M. GIBSON · 1997 · Neurochemical Research
  29. Biology of Aβ Amyloid in Alzheimer's Disease
    Thomas Wısnıewskı, Jorge A. Ghiso, Blas Frangione · 1997 · Neurobiology of Disease
  30. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.
    David M. A. Mann, Takeshi Iwatsubo, Yasuo Ihara, Nigel J. Cairns, Peter L Lantos, Nenad Bogdanović, Lars Lannfelt, Bengt G. Winblad, Marion L. C. Maat–Schieman, Martin N. Rossor · 1996 · Europe PMC (PubMed Central)
  31. p53-Dependent Cell Death Signaling in Neurons
    Richard S. Morrison, Yoshito Kinoshita, Mark D. Johnson, Weiqun Guo, Gwenn A. Garden · 2003 · Neurochemical Research
  32. Metal ions as modulators of protein conformation and misfolding in neurodegeneration
    Sónia S. Leal, Hugo M. Botelho, Cláudio M. Gomes · 2012 · Coordination Chemistry Reviews
  33. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner.
    Joseph D. Buxbaum, Astrid A. Ruefli, Christine A. Parker, Aaron Martin Cypess, Paul Greengard · 1994 · Proceedings of the National Academy of Sciences
  34. An aluminum-based rat model for Alzheimer’s disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration
    Judie R. Walton · 2007 · Journal of Inorganic Biochemistry
  35. Effects of in vivo conditions on amyloid aggregation
    Michael C. Owen, David Gnutt, Mimi Gao, Sebastian K.T.S. Wärmländer, Jüri Jarvet, Astrid Gräslund, Roland Winter, Simon Ebbinghaus, Birgit Strodel · 2019 · Chemical Society Reviews
  36. Amyloid β protein (Aβ) removal by neuroglial cells in culture
    Lillian M. Shaffer, Michael D. Dority, Rekha Gupta‐Bansal, Robert C.A. Frederickson, Steven G. Younkin, Kurt R. Brunden · 1995 · Neurobiology of Aging
  37. Genetics and molecular advances in Alzheimer's disease
    Mike Mullan, Fiona Crawford · 1993 · Trends in Neurosciences
  38. Cholesterol Is an Important Factor Affecting the Membrane Insertion of β-Amyloid Peptide (Aβ1–40), Which May Potentially Inhibit the Fibril Formation
    Shang‐Rong Ji, Yi Wu, Sen‐Fang Sui · 2002 · Journal of Biological Chemistry
  39. Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth.
    Edward H. Koo, L Park, Dennis J. Selkoe · 1993 · Proceedings of the National Academy of Sciences
  40. Role of gangliosides in Alzheimer’s disease
    Katsuhiko Yanagisawa · 2007 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  41. In-situ atomic force microscopy study of β-amyloid fibrillization
    H.K.L. Blackley, Giles H.W. Sanders, Martyn C. Davies, Clive J. Roberts, Saul J. B. Tendler, M.J Wilkinson · 2000 · Journal of Molecular Biology
  42. Genetic dissection of Alzheimer disease, a heterogeneous disorder.
    Gerard D. Schellenberg · 1995 · Proceedings of the National Academy of Sciences
  43. Production of intracellular amyloid‐containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence.
    Bart De Strooper, Mikael Simons, Gerd Multhaup, Fred VAN LEUVEN, Konrad T. Beyreuther, Carlos G. Dotti · 1995 · The EMBO Journal
  44. Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease
    Laura Gasparini, Marco Racchi, Giuliano Gb. Binetti, Marco Trabucchi, Sebastiano Bruno Solerte, Daniel L. Alkon, René Etcheberrigaray, Gary E. Gibson, John P. Blass, R. Paoletti et al. · 1998 · The FASEB Journal
  45. A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor
    Kaoru Miyazaki, Miki Launois Hasegawa, Kayano Funahashi, Makoto Umeda · 1993 · Nature
  46. Extracellular Tau Levels Are Influenced by Variability in Tau That Is Associated with Tauopathies
    Celeste M M. Karch, Amanda T. Jeng, Alison Goate · 2012 · Journal of Biological Chemistry
  47. Luteinizing Hormone, a Reproductive Regulator That Modulates the Processing of Amyloid-β Precursor Protein and Amyloid-β Deposition
    Richard L. Bowen, Giuseppe Verdile, Tianbing Liu, Albert F. Parlow, George L. Perry, Mark A. Smith, Ralph Nigel Martins, Craig Atwood · 2004 · Journal of Biological Chemistry
  48. Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerization
    Mark A. Findeis · 2000 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  49. The role of p53 in neuronal cell death
    Richard S. Morrison, Y Kinoshita · 2000 · Cell Death and Differentiation
  50. Hippocampal plasticity during the progression of Alzheimer’s disease
    Elliott Jay Mufson, Laura J. Mahady, D. Waters, Scott Counts, Sylvia E. Perez, Steven Trent DeKosky, Stephen D. Ginsberg, Miloš D. Ikonomović, Stephen W. Scheff, Lester I. Binder · 2015 · Neuroscience
  51. Interactions between APP secretases and inflammatory mediators
    Magdalena Sastre, Jochen Walter, Steve Gentleman · 2008 · Journal of Neuroinflammation
  52. Copper inhibits β -amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion
    Thilo Borchardt, James Camakaris, Roberto Cappai, Colin Louis Masters, Konrad T. Beyreuther, Gerd Multhaup · 1999 · Biochemical Journal
  53. Decreased β-amyloid 1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
    Markus Otto, Hermann Esselmann, Walter Schulz‐Schaeffer, Manuela Neumann, Andreas Schröter, Peter Ratzka, Lukas Cepek, Inga Zerr, Petra Steinacker, Otto Windl et al. · 2000 · Neurology
  54. 1H NMR of A.beta. Amyloid Peptide Congeners in Water Solution. Conformational Changes Correlate with Plaque Competence
    Jonathan P. Lee, Evelyn R. Stimson, Joseph R. Ghilardi, Patrick W. Mantyh, Yi-An Lu, Arthur M. Felix, William Llanos, Ali Behbin, Mike Cummings, Mark Van Criekinge et al. · 1995 · Biochemistry
  55. The sour side of neurodegenerative disorders: the effects of protein glycation
    Hugo Vicente Miranda, Tiago F. Outeiro · 2009 · The Journal of Pathology
  56. ?-amyloid Ca2+-channel hypothesis for neuronal death in Alzheimer Disease
    Nelson J. Arispe, Harvey B. Pollard, Eduardo Rojas · 1994 · Molecular and Cellular Biochemistry
  57. Serum levels of the iron binding protein p97 are elevated in Alzheimer′s disease
    Malcolm L. Kennard, Howard Feldman, Tatsuo Yamada, Wilfred Arthur Jefferies · 1996 · Nature Medicine
  58. The amyloid precursor protein of Alzheimer’s disease and the Aβ peptide
    Storey, Roberto Cappai · 1999 · Neuropathology and Applied Neurobiology
  59. Basal Forebrain Cholinergic Dysfunction in Alzheimer’s Disease – Interrelationship with β-amyloid, Inflammation and Neurotrophin Signaling
    Reinhard Schliebs · 2005 · Neurochemical Research
  60. The Amyloid β Peptide (Aβ 1 - 40 ) Is Thermodynamically Soluble at Physiological Concentrations
    Parijat Sengupta, Kanchan Garai, Bankanidhi Sahoo, Yuan Shi, David J.E. Callaway, Sudipta Maiti · 2003 · Biochemistry
  61. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1
    Saumya Das, Huntington Potter · 1995 · Neuron
  62. Soluble β-Amyloid Induction of Alzheimer's Phenotype for Human Fibroblast K + Channels
    René Etcheberrigaray, Etsuro Ito, Christopher S. Kim, Daniel L. Alkon · 1994 · Science
  63. Amyloid peptide attenuates the proteasome activity in neuronal cells
    Sangsoo Oh, Hyun‐Seok Hong, Enmi Hwang, Hae Jin Sim, Woojin Lee, Su Jeon Shin, Inhee Mook‐Jung · 2005 · Mechanisms of Ageing and Development
  64. Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25–35
    Yury G. Kaminsky, Michael W. Marlatt, Mark A. Smith, Elena A. Kosenko · 2009 · Experimental Neurology
  65. APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and a beta 1-40) in familial Alzheimer's disease brain
    Akira Tamaoka, Asano Odaka, Y Ishibashi, M Usami, Naruhiko Sahara, Nobuhiro Suzuki, Nobuyuki Nukina, Hidehiro Mizusawa, S Shoji, Ichiro Kanazawa · 1994 · Journal of Biological Chemistry
  66. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization.
    Frank M. LaFerla, Juan Carlos Troncoso, Dudley K. Strickland, Claudia H. Kawas, Gregory D. Jay · 1997 · Journal of Clinical Investigation
  67. Disrupting β-Amyloid Aggregation for Alzheimer Disease Treatment
    Lisbell D. Estrada, Claudio A. Soto · 2006 · Current Topics in Medicinal Chemistry
  68. Amyloids and Are Generated Intracellularly in Cultured Human Neurons and Their Secretion Increases with Maturation
    Turner, R. Scott, Suzuki, Nobuhiro, Chyung, Abraham S.C., Younkin, Steven G., Lee, Virginia M.-Y. · 1996 · Journal of Biological Chemistry
  69. Intramembrane proteolysis by presenilins
    Steiner, Harald, Haass, Christian · 2000 · Nature Reviews Molecular Cell Biology
  70. Beta A4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons.
    Rupert Sandbrink, Colin Louis Masters, Konrad T. Beyreuther · 1994 · Journal of Biological Chemistry
  71. The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system
    Cheryl A. Hawkes, Satyabrata Kar · 2004 · Brain Research Reviews
  72. Amyloidogenicity of rodent and human βA4 sequences
    Thomas Dyrks, Elke Dyrks, Colin Louis Masters, Konrad T. Beyreuther · 1993 · FEBS Letters
  73. Metal Ion-dependent Effects of Clioquinol on the Fibril Growth of an Amyloid β Peptide
    Bakthisaran Raman, Tadato Ban, Kei‐ichi Yamaguchi, Miyo Sakai, Tomoji Kawai, Hironobu Naiki, Yuji Goto · 2005 · Journal of Biological Chemistry
  74. The Carboxyl Termini of β-Amyloid Peptides 1-40 and 1-42 Are Generated by Distinct γ-Secretase Activities
    Hans‐Wolfgang Klafki, Dorothée Abramowski, Robert Swoboda, Paolo Paganetti, Matthias Staufenbiel · 1996 · Journal of Biological Chemistry
  75. Expression of Scavenger Receptors in Glial Cells
    Rodrigo Alarcón, Carolina Fuenzalida, Marcos Santibáñez, Rommy von Bernhardi M. · 2005 · Journal of Biological Chemistry
  76. Relationship between β-amyloid degradation and the 26S proteasome in neural cells
    M. Lopez Salon, Laura Andrea Pasquini, M Besio Moreno, Juana Maria Pasquini, Eduardo F. Soto · 2003 · Experimental Neurology
  77. Ruthenium( ii ) complexes with dppz: from molecular photoswitch to biological applications
    Guanying Li, Lingli Sun, Liang‐Nian Ji, Hui Chao · 2016 · Dalton Transactions
  78. γ-Secretase, Evidence for Multiple Proteolytic Activities and Influence of Membrane Positioning of Substrate on Generation of Amyloid β Peptides of Varying Length
    Michael Paul Murphy, Lesley Hickman, Christopher B. Eckman, Sacha Uljon, Rong Wang, Todd Eliot Golde · 1999 · Journal of Biological Chemistry
  79. Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease
    Giulio Maria Pasinetti, Jacqueline A. Eberstein · 2008 · Journal of Neurochemistry
  80. Increased production of 4 kDa amyloid beta peptide in serum deprived human primary neuron cultures: possible involvement of apoptosis
    Andrea Claire LeBlanc · 1995 · Journal of Neuroscience
  81. Presenilins and Alzheimer’s disease: biological functions and pathogenic mechanisms
    Christian Czech, Günter L. Tremp, Laurent Pradier · 2000 · Progress in Neurobiology
  82. Novel Mechanistic Insight into the Molecular Basis of Amyloid Polymorphism and Secondary Nucleation during Amyloid Formation
    Jae Sun Jeong, Annalisa Ansaloni, Raffaele Mezzenga, Hilal Ahmed Lashuel, Giovanni Dietler · 2013 · Journal of Molecular Biology
  83. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
    Mark P. Mattson · 1994 · PubMed
  84. Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues.
    Takami Tomiyama, Satoshi Asano, Yoshiko Furiya, Takuji Shirasawa, Noriaki Endo, Hiroshi Mori · 1994 · Journal of Biological Chemistry
  85. Amyloid β protein in plasma from patients with sporadic Alzheimer's disease
    Akira Tamaoka, Tetsuo Fukushima, Naoya Sawamura, Kin'ya Ishikawa, Eiichi Oguni, Yasuko Komatsuzaki, Shin’ichi Shoji · 1996 · Journal of the Neurological Sciences
  86. Dementia of the eye: the role of amyloid beta in retinal degeneration
    J. Arjuna Ratnayaka, Louise C. Serpell, Andrew John Lotery · 2015 · Eye
  87. Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway.
    Bart De Strooper, Lieve Umans, F. Van Leuven, Herman VAN DEN BERGHE · 1993 · The Journal of Cell Biology
  88. Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structure
    Claudio A. Soto, Eduardo Miguel Castaño, Rashmi Kumar, Ronald C. Beavis, Blas Frangione · 1995 · Neuroscience Letters
  89. Isoform‐Specific Effects of Apolipoproteins E2, E3, and E4 on Cerebral Capillary Sequestration and Blood‐Brain Barrier Transport of Circulating Alzheimer's Amyloid β
    Martel, Cynthia L., Mackic, Jasmina B., Matsubara, Etsuro, Governale, Samuel, Miguel, Calero, Miao, Wesley, McComb, J. Gordon, Frangione, Blas, Ghiso, Jorge, Zlokovic, Berislav V. · 1997 · Journal of Neurochemistry
  90. Solution Structure of Residues 1-28 of the Amyloid .beta.-Peptide
    Joseph Talafous, Keith J. Marcinowski, Gilles Klopman, Michael G. Zagorski · 1994 · Biochemistry
  91. Nanotechnology Solutions for Alzheimer's Disease: Advances in Research Tools, Diagnostic Methods and Therapeutic Agents
    Amir Nazem, G. Ali Mansoori · 2008 · Journal of Alzheimer s Disease
  92. αB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid β-peptide and β2-microglobulin
    Bakthisaran Raman, Tadato Ban, Miyo Sakai, Saloni Yatin Pasta, Tangirala Ramakrishna, Hironobu Naiki, Yuji Goto, Ch. Mohan Rao · 2005 · Biochemical Journal
  93. Genomics of Alzheimer Disease
    Roger N. Rosenberg, Doris Lambracht‐Washington, Gang Yu, Weiming Xia · 2016 · JAMA Neurology
  94. Aluminum-Induced Structural Alterations of the Precursor of the Non-Aβ Component of Alzheimer's Disease Amyloid
    Seung R. Paik, Ju‐Hyun Lee, Do-Hyung Kim, Chung‐Soon Chang, Jongsun Kim · 1997 · Archives of Biochemistry and Biophysics
  95. Presenilin-1 differentially facilitates endoproteolysis of the β-amyloid precursor protein and Notch
    Anja Capell, Harald Steiner, Helmut Romig, Simone Keck, Miriam Baader, Melissa G. Grim, Ralf Baumeister, Christian Haass · 2000 · Nature Cell Biology
  96. THE GENETICS AND MOLECULAR PATHOLOGY OF ALZHEIMER'S DISEASE
    Dennis J. Selkoe · 2000 · Neurologic Clinics
  97. Advanced Maillard Reaction End Products, Free Radicals, and Protein Oxidation in Alzheimer's Diseasea
    Mark A. Smith, Peggy L. Richey, Shinji Taneda, R. Krishnan Kutty, Sayre Lm, Vincent M. Monnier, George L. Perry · 1994 · Annals of the New York Academy of Sciences
  98. Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular site of catabolism
    Jeffrey N. Higaki, Diana H. Quon, Ziyang Zhong, Barbara Cordell · 1995 · Neuron
  99. Advanced glycation and endothelial functions: A link towards vascular complications in diabetes
    Armando Rojas R, Miguel Angel Morales · 2004 · Life Sciences
  100. Alzheimer’s Disease as Proteolytic Disorders: Anabolism and Catabolism of β-Amyloid
    Takaomi C. Saido · 1998 · Neurobiology of Aging